Recently, the dysregulation of interferon (IFN) signaling pathways, especially upregulation of type I IFN-inducible genes, has been observed in salivary glands and peripheral blood in a subset of SS patients (6– 10). The gene discussed is IFNA1; the disease is synovial sarcoma.